Strain differences in cytochrome P450 mRNA and protein expression, and enzymatic activity among Sprague Dawley, Wistar, Brown Norway and Dark Agouti rats

Access this Article

Author(s)

    • NISHIYAMA Yoshihiro
    • Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, 18 W9, Kita-ku, Sapporo 060–0818, Japan
    • NAKAYAMA Shouta M.M.
    • Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, 18 W9, Kita-ku, Sapporo 060–0818, Japan
    • WATANABE Kensuke P.
    • Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, 18 W9, Kita-ku, Sapporo 060–0818, Japan
    • KAWAI Yusuke K.
    • Diagnostic Center for Animal Health and Food Safety, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080–8555, Japan
    • OHNO Marumi
    • Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, 18 W9, Kita-ku, Sapporo 060–0818, Japan
    • IKENAKA Yoshinori
    • Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, 18 W9, Kita-ku, Sapporo 060–0818, Japan|Water Research Group, Unit for Environmental Sciences and Management, North-West University, Potchefstroom, South Africa
    • ISHIZUKA Mayumi
    • Laboratory of Toxicology, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University, 18 W9, Kita-ku, Sapporo 060–0818, Japan

Abstract

Rat cytochrome P450 (CYP) exhibits inter-strain differences, but their analysis has been scattered across studies under different conditions. To identify these strain differences in CYP more comprehensively, mRNA expression, protein expression and metabolic activity among Wistar (WI), Sprague Dawley (SD), Dark Agouti (DA) and Brown Norway (BN) rats were compared. The mRNA level and enzymatic activity of CYP1A1 were highest in SD rats. The rank order of <i>Cyp3a2</i> mRNA expression mirrored its protein expression, i.e., DA>BN>SD>WI, and was similar to the CYP3A2-dependent warfarin metabolic activity, i.e., DA>SD>BN>WI. These results suggest that the strain differences in CYP3A2 enzymatic activity are caused by differences in mRNA expression. <i>Cyp2b1</i> mRNA levels, which were higher in DA rats, did not correlate with its protein expression or enzymatic activity. This suggests that the strain differences in enzymatic activity are not related to <i>Cyp2b1</i> mRNA expression. In conclusion, WI rats tended to have the lowest CYP1A1, 2B1 and 3A2 mRNA expression, protein expression and enzymatic activity among the strains. In addition, SD rats had the highest CYP1A1 mRNA expression and activity, while DA rats had higher CYP2B1 and CYP3A2 mRNA and protein expression. These inter-strain differences in CYP could influence pharmacokinetic considerations in preclinical toxicological studies.

Journal

  • Journal of Veterinary Medical Science

    Journal of Veterinary Medical Science 78(4), 675-680, 2016

    JAPANESE SOCIETY OF VETERINARY SCIENCE

Codes

  • NII Article ID (NAID)
    130007331491
  • Text Lang
    ENG
  • ISSN
    0916-7250
  • Data Source
    J-STAGE 
Page Top